NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the expansion of its customer network within the UK retail sector. This includes the adoption of INBS’ Intelligent Fingerprinting Drug Screening System by three prominent UK retailers, among the largest and most recognized in the country.
The recently secured accounts employ over 55,000 individuals and include a British multinational retailer specializing in clothing, footwear, and accessories, a major UK-based kitchen retailer and manufacturer, and a British retail group specializing in sports and leisure clothing, footwear, and equipment. Two retailers have transitioned from traditional third-party saliva testing to INBS’s fingerprint drug screening technology. The switch to a more streamlined, hygienic, and less invasive testing methodology has addressed business and policy alignment issues and previous testing inefficiencies, facilitating smoother processes that enable larger testing volumes.
Doug Heath, Vice president of Global Sales at INBS, commented, “Our reach continues to extend into new sectors, indicating a demand for drug testing beyond just safety-critical industries. We’re seeing more businesses taking proactive measures to ensure workplace safety and protect their reputation as responsible employers. We are very pleased to welcome these prominent retail partners into our growing network.”
INBS’ first-of-its-kind solution uses fingerprint sweat to provide a quick, hygienic, and easy-to-use method for drug testing, delivering results in just minutes. This unique approach tests for common drugs of abuse, including cocaine, cannabis, methamphetamine, and opiates.
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering innovative, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. Additionally, the Company’s biosensor platform has the potential to test for various indications, ranging from immunological conditions to communicable diseases. The Company’s current customer segments include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners.
For more information, visit: http://www.ibs.inc/
